Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIRSA001: Anti-Inflammatory Reliever Therapy for Asthma in South African Children
NCT06429475Phase 3Recruiting
- Sponsor
- University of KwaZulu-Natal
- Start
- Jun 2024
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide + formoterol in asthma, sponsored by University of KwaZulu-Natal. Started Jun 2024; status: recruiting.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06429475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06429475.